Is this Seattle Penny Pot Stock a Potential Blockbuster?
A small, rapidly expanding Seattle cannabis company is gaining attention from investors. Founded by two cannabis veterans, the company has increased sales 8-fold and is looking to double sales again in the next two years. Now selling for less than $1 per share, this is an opportunity to acquire thousands of shares – a potential windfall.
Get Free Report on #1 Cannabis Pick for 2021

CHM Insider Trading (Chimeric Therapeutics)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$7,886.40
Insider Selling (Last 12 Months): A$0.00

Chimeric Therapeutics Insider Trading History Chart

Chimeric Therapeutics Share Price & Price History

A$0.00
+0.30 (1.20%)
As of 03/11/2021 11:04 AM ET
Peter Thiel Bets Big On "Mushroom Boom."
LSD and "Mushroom stocks" are being listed on the NASDAQ and a recent breakthrough makes top investors VERY excited about the coming "Mushroom Boom."
Click Here To Read The Full Story

Chimeric Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/8/2021Cynthia ElkinsInsiderBuy24,800A$0.32A$7,886.40
See Full Table
Chimeric Therapeutics logo
Chimeric Therapeutics Limited, a biotechnology company, develops and commercializes chimeric antigen receptor T cell therapy drugs for solid tumors in Australia. It is developing CLTX-CAR T cell therapy that is Phase I clinical study in Glioblastoma. The company was incorporated in 2020 and is based in Carlton, Australia.
Read More on Chimeric Therapeutics

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Chimeric Therapeutics?

Chimeric Therapeutics' top insider shareholders include:
  1. Cynthia Elkins (Insider)
Is this Seattle Penny Pot Stock a Potential Blockbuster?
A small, rapidly expanding Seattle cannabis company is gaining attention from investors. Founded by two cannabis veterans, the company has increased sales 8-fold and is looking to double sales again in the next two years. Now selling for less than $1 per share, this is an opportunity to acquire thousands of shares – a potential windfall.
Get Free Report on #1 Cannabis Pick for 2021